New DMSO combo therapy aims to quiet tinnitus in long COVID patients
Symptom relief
Not yet recruiting
This pilot study tests a DMSO-based ear drop and cream for adults with chronic tinnitus linked to long COVID or COVID-19 vaccine injury. Twenty participants will use both treatments for 30 days. The main goal is to see if at least half of them get a 50% or greater reduction in ti…
Phase: PHASE2 • Sponsor: Leading Edge Clinic • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC